https://www.selleckchem.com/products/nvl-655.html
TRT showed less microscopic edema (2/13 [15.4%] vs 8/13 [61.5%]; p = 0.044) as well as no increase in cytokines levels. All adverse events were categorized as "grade 1" (asymptomatic; mild). The most interesting part of this study was the improvement in smell between baseline (T and week 24 (T2) in TRT only (p = 0.041). Transnasal tretinoin associated with budesonide was safe and well tolerated, and it should be investigated as a treatment option for some CRSwNP endotypes. ©2021 ARSAAOA, LLC. Transnasal tretinoin associated with budes
Respect!
Kommentar
Delen
